跳至主要内容
临床试验/NCT01823484
NCT01823484Unknown不适用

Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill

Zhongda Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
1
主要终点
The using time of hemofilters

研究概览

简要总结

Compared with AN69 hemofilter, AN69 ST hemofilter may prolong the time of hemofilter and decrease the quantity of heparin during continuous renal replacement therapy in critically ill.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age> 18 years old
  • admitted to ICU and need CRRT
  • anticipated survival time >72h

排除标准

  • allergy to hemofilter or heparin
  • heparin associated thrombocytopenia
  • pregnancy or lactation
  • using other anticoagulate drugs

结局指标

主要结局

The using time of hemofilters

时间窗: 72h

The time from the beginning of continuous renal replacement therapy until to the end when continuous renal replacement therapy had to be finished because of clotting or other reasons

次要结局

  • activated partial thromboplastin time(every 6h from the begining of continuous renal replacement therapy,up to 72h)

研究者

发起方
Zhongda Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaohua Qiu

physician

Zhongda Hospital

研究点 (1)

Loading locations...

相似试验